{
  "main_header": {
    "sid": 525226,
    "name": "Indrayani Biotec",
    "stock_name": "Indrayani Biotec",
    "full_name": "Indrayani Biotech Ltd",
    "name_url": "stocks-analysis/indrayani-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.51",
    "chg": -0.15,
    "chgp": "-1.1%",
    "dir": -1,
    "prev_price": "13.66",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526445,
    "symbol": "",
    "ind_name": "Other Agricultural Products",
    "ind_code": 101,
    "indexname": "",
    "isin": "INE007C01021",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "1.31 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indrayani-biotec-525226-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Indrayani Biotec latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indrayani-biotec-latest-results-good-or-bad-3757633",
        "imagepath": "",
        "date": "2025-12-12 19:12:34",
        "description": "Indrayani Biotech's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.91 crores, reflecting a substantial sequential recovery of 468.75% from the previous quarter. However, this figure represents a decline of 25.41% compared to the same quarter last year. Revenue for the quarter was ₹35.95 crores, showing a quarter-on-quarter growth of 23.54% and a year-on-year increase of 16.68%. \n\nDespite the revenue growth, the company's operating margin has significantly compressed, falling to 6.82% from 23.76% in the same quarter last year, indicating operational challenges and inefficiencies. The profit after tax margin also decreased to 2.53% from 3.96% year-on-year, further highlighting the difficulties in maintaining profitability amidst rising costs, particularly employee expenses, which surged by 47.58% sequentially.\n\nThe financial metrics indicate that while ..."
      },
      {
        "title": "Indrayani Biotech Reports Flat Quarterly Performance Amid Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indrayani-biotechs-quarterly-financial-performance-shows-signs-of-stabilisation-amid-prolonged-downtrend-3757393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndrayaniBiotec_fintrenddot_3757393.png",
        "date": "2025-12-12 11:00:07",
        "description": "Indrayani Biotech's latest quarterly results for September 2025 reveal a stabilisation in financial performance following a period of decline, with key metrics showing a shift from negative trends to a more neutral footing. Despite ongoing challenges in profitability and market returns, the company’s recent figures offer a nuanced view of its operational and financial health within the Other Agricultural Products sector."
      },
      {
        "title": "Indrayani Biotech Q2 FY26: Profit Recovery Masks Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/indrayani-biotech-q2-fy26-profit-recovery-masks-deepening-operational-crisis-3757262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndrayaniBiotec_quaterlyResult_3757262.png",
        "date": "2025-12-12 09:45:39",
        "description": "Indrayani Biotech Ltd., a micro-cap agricultural products company, reported a consolidated net profit of ₹0.91 crores in Q2 FY26, marking a dramatic 468.75% quarter-on-quarter surge from ₹0.16 crores in Q1 FY26. However, this apparent recovery conceals a troubling reality: year-on-year profit declined 25.41%, whilst the company's operating margins collapsed to just 6.82%, down sharply from 23.76% in the corresponding quarter last year. The stock, currently trading at ₹14.31 with a market capitalisation of ₹63.00 crores, has plummeted 60.46% over the past year, reflecting deep investor scepticism about the company's operational viability."
      },
      {
        "title": "Indrayani Biotec Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indrayani-biotec-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3749865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndrayaniBiotec_mojoScore_3749865.png",
        "date": "2025-12-06 10:10:14",
        "description": "Indrayani Biotec, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors."
      },
      {
        "title": "Why is Indrayani Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indrayani-biotec-fallingrising-3747179",
        "imagepath": "",
        "date": "2025-12-05 00:45:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Price Movement and Sector Influence</strong></p>\n<p>Indrayani Biotec’s share price fell by 2.37% on 04 December, aligning closely with the broader floriculture sector, which itself declined by 2.29% on the same day. This parallel movement suggests that sector-wide factors are influencing the stock’s performance. The company’s price today was positioned above its 50-day and 100-day moving averages, indicating some underlying support at these levels. However, it remained below its 5-day, 20-day, and 200-day moving averages, signalling short-term weakness and a lack of upward momentum in recent trading sessions.</p>\n<p><strong>Trading Activity and Liquidity</strong></p>\n<p>Investor participation in Indrayani Biotec has shown signs of increase, with delivery volume on 03 December rising ..."
      },
      {
        "title": "How has been the historical performance of Indrayani Biotec?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indrayani-biotec-3702841",
        "imagepath": "",
        "date": "2025-11-14 23:35:17",
        "description": "Answer:\nThe historical performance of Indrayani Biotec has shown significant fluctuations over the years, particularly in net sales and profitability.\n\nBreakdown:\nIndrayani Biotec's net sales peaked at 166.23 Cr in March 2024 but fell to 130.23 Cr by March 2025. The total operating income followed a similar trend, decreasing from 166.23 Cr in March 2024 to 130.23 Cr in March 2025. The company experienced a notable increase in raw material costs, which reached 82.77 Cr in March 2025, down from 97.13 Cr in March 2024. Operating profit (PBDIT) also declined from 24.66 Cr in March 2024 to 18.36 Cr in March 2025, while profit before tax turned negative at -5.74 Cr in March 2025 after being positive at 10.97 Cr in March 2024. Consequently, the profit after tax also fell to -6.11 Cr in March 2025 from 10.42 Cr in March 2024. The earnings per share (EPS) reflected this downturn, dropping to -1.34 in March 2025 from..."
      },
      {
        "title": "Are Indrayani Biotec latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indrayani-biotec-latest-results-good-or-bad-3702163",
        "imagepath": "",
        "date": "2025-11-14 19:27:00",
        "description": "Indrayani Biotech has reported its financial results for the quarter ending June 2025, reflecting significant challenges in its operational performance. The company's net sales amounted to Rs 29.10 crore, which represents a year-on-year decline of 7.71%. This decline in sales is notable, especially when compared to the previous year's performance.\n\nThe Profit Before Tax (PBT) has fallen to Rs -0.85 crore, indicating a substantial decline year-on-year. Similarly, the Profit After Tax (PAT) has decreased to Rs 0.16 crore, showing an 81.18% reduction compared to the same quarter last year. These figures suggest that the company is facing considerable pressure on its profitability.\n\nAdditionally, the inventory turnover ratio has reached a low of 3.15 times, which may signal a slowdown in inventory movement and could raise concerns about operational efficiency. The non-operating income has increased significantl..."
      },
      {
        "title": "Why is Indrayani Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indrayani-biotec-fallingrising-3698481",
        "imagepath": "",
        "date": "2025-11-13 21:38:23",
        "description": "As of 13-Nov, Indrayani Biotech Ltd's stock price is currently at 14.78, reflecting a decrease of 0.29, or 1.92%. The stock has been experiencing a downward trend, having lost 3.46% over the last two days, and it has underperformed significantly over the past year with a decline of 65.14%. The stock's performance today is in line with the sector, which has also seen a decline of 2.04%. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 90.13% compared to the 5-day average, indicating reduced interest in trading the stock. The stock is currently trading above its 20-day, 50-day, and 100-day moving averages but below its 5-day and 200-day moving averages, suggesting mixed signals regarding its short-term momentum.\n\nBroader Market Context: In the context of the broader market, the Sensex has gained 1.40% over the past week, contrasting sharply with Indrayani ..."
      },
      {
        "title": "Why is Indrayani Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indrayani-biotec-fallingrising-3676567",
        "imagepath": "",
        "date": "2025-11-06 21:24:43",
        "description": "As of 06-Nov, Indrayani Biotech Ltd's stock price is currently at 15.60, reflecting an increase of 1.34, or 9.4%. The stock has been gaining momentum, having risen for the last two days with a total return of 11.67% during this period. It opened with a gain of 4.77% today and reached an intraday high of Rs 16.47, although it also experienced a low of Rs 13.72. The stock has shown high volatility today, with an intraday volatility of 9.07%. Additionally, the stock's performance over the past week has been strong, with a return of 11.43%, contrasting sharply with the Sensex, which declined by 1.30%. However, the stock is still down significantly year-to-date by 57.12% and has a longer-term decline of 66.73% over the past year.\n\nIn the broader market context, while Indrayani Biotech's short-term performance has outpaced the benchmark Sensex, which gained only 1.86% over the past month, the stock's year-to-date..."
      }
    ],
    "total": 688,
    "sid": "525226",
    "stock_news_url": "https://www.marketsmojo.com/news/indrayani-biotech-525226"
  },
  "announcements": [
    {
      "caption": "Intimation Of Fine Levied By BSE",
      "datetime": "17-Dec-2025",
      "details": "BSE has levied a fine on the Company due to non-submission of financial results for the Quarter ended 30th September 2025 within the period as prescribed under Regulation 33 of SEBI LODR",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Dec-2025",
      "details": "Newspaper Advertisement on special window for re-lodgement of transfer requests of physical shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Dec-2025",
      "details": "Newspaper publication for Q2 results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Indrayani Biotec latest results good or bad?

2025-12-12 19:12:34

Indrayani Biotech's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.91 crores, reflecting a substantial sequential recovery of 468.75% from the previous quarter. However, this figure represents a decline of 25.41% compared to the same quarter last year. Revenue for the quarter was ₹35.95 crores, showing a quarter-on-quarter growth of 23.54% and a year-on-year increase of 16.68%. Despite the revenue growth, the company's operating margin has significantly compressed, falling to 6.82% from 23.76% in the same quarter last year, indicating operational challenges and inefficiencies. The profit after tax margin also decreased to 2.53% from 3.96% year-on-year, further highlighting the difficulties in maintaining profitability amidst rising costs, particularly employee expenses, which surged by 47.58% sequentially. The financial metrics indicate that while ...

Read More

Indrayani Biotech Reports Flat Quarterly Performance Amid Challenging Market Conditions

2025-12-12 11:00:07

Indrayani Biotech's latest quarterly results for September 2025 reveal a stabilisation in financial performance following a period of decline, with key metrics showing a shift from negative trends to a more neutral footing. Despite ongoing challenges in profitability and market returns, the company’s recent figures offer a nuanced view of its operational and financial health within the Other Agricultural Products sector.

Read More

Indrayani Biotech Q2 FY26: Profit Recovery Masks Deepening Operational Crisis

2025-12-12 09:45:39

Indrayani Biotech Ltd., a micro-cap agricultural products company, reported a consolidated net profit of ₹0.91 crores in Q2 FY26, marking a dramatic 468.75% quarter-on-quarter surge from ₹0.16 crores in Q1 FY26. However, this apparent recovery conceals a troubling reality: year-on-year profit declined 25.41%, whilst the company's operating margins collapsed to just 6.82%, down sharply from 23.76% in the corresponding quarter last year. The stock, currently trading at ₹14.31 with a market capitalisation of ₹63.00 crores, has plummeted 60.46% over the past year, reflecting deep investor scepticism about the company's operational viability.

Read More

Indrayani Biotec Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-06 10:10:14

Indrayani Biotec, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors.

Read More

Why is Indrayani Biotec falling/rising?

2025-12-05 00:45:36

Current Price Movement and Sector Influence

Indrayani Biotec’s share price fell by 2.37% on 04 December, aligning closely with the broader floriculture sector, which itself declined by 2.29% on the same day. This parallel movement suggests that sector-wide factors are influencing the stock’s performance. The company’s price today was positioned above its 50-day and 100-day moving averages, indicating some underlying support at these levels. However, it remained below its 5-day, 20-day, and 200-day moving averages, signalling short-term weakness and a lack of upward momentum in recent trading sessions.

Trading Activity and Liquidity

Investor participation in Indrayani Biotec has shown signs of increase, with delivery volume on 03 December rising ...

Read More

How has been the historical performance of Indrayani Biotec?

2025-11-14 23:35:17

Answer: The historical performance of Indrayani Biotec has shown significant fluctuations over the years, particularly in net sales and profitability. Breakdown: Indrayani Biotec's net sales peaked at 166.23 Cr in March 2024 but fell to 130.23 Cr by March 2025. The total operating income followed a similar trend, decreasing from 166.23 Cr in March 2024 to 130.23 Cr in March 2025. The company experienced a notable increase in raw material costs, which reached 82.77 Cr in March 2025, down from 97.13 Cr in March 2024. Operating profit (PBDIT) also declined from 24.66 Cr in March 2024 to 18.36 Cr in March 2025, while profit before tax turned negative at -5.74 Cr in March 2025 after being positive at 10.97 Cr in March 2024. Consequently, the profit after tax also fell to -6.11 Cr in March 2025 from 10.42 Cr in March 2024. The earnings per share (EPS) reflected this downturn, dropping to -1.34 in March 2025 from...

Read More

Are Indrayani Biotec latest results good or bad?

2025-11-14 19:27:00

Indrayani Biotech has reported its financial results for the quarter ending June 2025, reflecting significant challenges in its operational performance. The company's net sales amounted to Rs 29.10 crore, which represents a year-on-year decline of 7.71%. This decline in sales is notable, especially when compared to the previous year's performance. The Profit Before Tax (PBT) has fallen to Rs -0.85 crore, indicating a substantial decline year-on-year. Similarly, the Profit After Tax (PAT) has decreased to Rs 0.16 crore, showing an 81.18% reduction compared to the same quarter last year. These figures suggest that the company is facing considerable pressure on its profitability. Additionally, the inventory turnover ratio has reached a low of 3.15 times, which may signal a slowdown in inventory movement and could raise concerns about operational efficiency. The non-operating income has increased significantl...

Read More

Why is Indrayani Biotec falling/rising?

2025-11-13 21:38:23

As of 13-Nov, Indrayani Biotech Ltd's stock price is currently at 14.78, reflecting a decrease of 0.29, or 1.92%. The stock has been experiencing a downward trend, having lost 3.46% over the last two days, and it has underperformed significantly over the past year with a decline of 65.14%. The stock's performance today is in line with the sector, which has also seen a decline of 2.04%. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 90.13% compared to the 5-day average, indicating reduced interest in trading the stock. The stock is currently trading above its 20-day, 50-day, and 100-day moving averages but below its 5-day and 200-day moving averages, suggesting mixed signals regarding its short-term momentum. Broader Market Context: In the context of the broader market, the Sensex has gained 1.40% over the past week, contrasting sharply with Indrayani ...

Read More

Why is Indrayani Biotec falling/rising?

2025-11-06 21:24:43

As of 06-Nov, Indrayani Biotech Ltd's stock price is currently at 15.60, reflecting an increase of 1.34, or 9.4%. The stock has been gaining momentum, having risen for the last two days with a total return of 11.67% during this period. It opened with a gain of 4.77% today and reached an intraday high of Rs 16.47, although it also experienced a low of Rs 13.72. The stock has shown high volatility today, with an intraday volatility of 9.07%. Additionally, the stock's performance over the past week has been strong, with a return of 11.43%, contrasting sharply with the Sensex, which declined by 1.30%. However, the stock is still down significantly year-to-date by 57.12% and has a longer-term decline of 66.73% over the past year. In the broader market context, while Indrayani Biotech's short-term performance has outpaced the benchmark Sensex, which gained only 1.86% over the past month, the stock's year-to-date...

Read More

View All News